Patterns in bacterial-and viral-induced immunosuppression and secondary infections in the ICU

Shock

Volumn 47, Issue 1, 2017, Pages 5-12

  Koch, Rebecca M ^a   Kox, Matthijs ^a   De Jonge, Marien I ^a   Van Der Hoeven, Johannes G ^a   Ferwerda, Gerben ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HRV; Immune suppression; Influenza; IPA; RSV; Sepsis; Superinfections; Viral reactivation

Indexed keywords

BACTERIAL INFECTION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RHINOVIRUS; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA VIRUS; INTENSIVE CARE UNIT; NONHUMAN; REVIEW; SECONDARY INFECTION; SUPERINFECTION; VIRUS INFECTION; VIRUS REACTIVATION; IMMUNOLOGY; INFLUENZA A VIRUS; MIXED INFECTION; PATHOGENICITY; PNEUMOVIRUS; STATISTICS AND NUMERICAL DATA;

COINFECTION; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS; INTENSIVE CARE UNITS; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84981722758     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000731     Document Type: Review

References (34)

1. Grimaldi D, Llitjos JF, Pene F: Post-infectious immune suppression: a new paradigm of severe infections. Med Mal Infect 44(10):455-463, 2014.
2. Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260-268, 2013.
3. Schmid-Hempel P: Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence. Philos Trans R Soc Lond B Biol Sci 364(1513):85-98, 2009.
4. Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P: Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunos-timulation. Time for a paradigm change? Am J Respir Crit Care Med 187(12):1287-1293, 2013.
5. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, et al.: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23):2594-2605, 2011.
6. Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, Pachot A, Brooks TL, Deych E, Shannon WD, et al.: Reactivation of multiple viruses in patients with sepsis. PLoS One 9(2):e98819, 2014.
7. Sajjan U, Ganesan S, Comstock AT, Shim J, Wang Q, Nagarkar DR, Zhao Y, Goldsmith AM, Sonstein J, Linn MJ, et al.: Elastase-and LPS-exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 297(5):L931-L944, 2009.
8. Lee KY, Rhim JW, Kang JH: Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses 76(1):64-69, 2011.
9. McCullers JA: Insights into the interaction between influenza virus and pneumo-coccus. Clin Microbiol Rev 19(3):571-582, 2006.
10. Diavatopoulos DA, Short KR, Price JT, Wilksch JJ, Brown LE, Briles DE, Strugnell RA, Wijburg OL: Influenza Avirus facilitates Streptococcus pneumo-niae transmission and disease. FASEB J 24(6):1789-1798, 2010.
11. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, Lawrence T, van Rijt LS, Lambrecht BN, Sirard JC, et al.: Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 205(2):323-329, 2008.
12. Smith MW, Schmidt JE, Rehg JE, Orihuela CJ, McCullers JA: Induction of pro-and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp Med 57(1):82-89, 2007.
13. Morens DM, Taubenberger JK, Fauci AS: Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198(7):962-970, 2008.
14. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC: Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119(7):1910-1920, 2009.
15. Bakaletz LO: Immunopathogenesis of polymicrobial otitis media. J Leukoc Biol 87(2):213-222, 2010.
16. Kudva A, Scheller EV, Robinson KM, Crowe CR, Choi SM, Slight SR, Khader SA, Dubin PJ, Enelow RI, Kolls JK, et al.: Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 186(3):1666-1674, 2011.
17. Small CL, Shaler CR, McCormick S, Jeyanathan M, Damjanovic D, Brown EG, Arck P, Jordana M, Kaushic C, Ashkar AA, et al.: Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 184(4):2048-2056, 2010.
18. van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, Florquin S, Goldman M, Jansen HM, Lutter R, van der Poll T: IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 172(12):7603-7609, 2004.
19. Sun K, Metzger DW: Inhibition of pulmonary antibacterial defense by inter-feron-gamma during recovery from influenza infection. Nat Med 14(5):558-564, 2008.
20. Lehmann C, Sprenger H, Nain M, Bacher M, Gemsa D: Infection of macro-phages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res Virol 147(2-3):123-130, 1996.
21. Duan X, Lu J, Zhou K, Wang J, Wu J, Gao GF, Fang M: Natural Killer Cells are involved in Thymic Atrophy induced by Influenza AVirus Infection. J Gen Virol 96(11):3223-3235, 2015.
22. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, Lagrou K, Wilmer A, Jorens P, Hermans G: Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 38(11):1761-1768, 2012.
23. Larranaga CL, Ampuero SL, Luchsinger VF, Carrion FA, Aguilar NV, Morales PR, Palomino MA, Tapia LF, Avendaño LF: Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 28(10):867-873, 2009.
24. Raza MW, Blackwell CC, Elton RA, Weir DM: Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus. J Med Microbiol 49(3):227-233, 2000.
25. Kallal LE, Hartigan AJ, Hogaboam CM, Schaller MA, Lukacs NW: Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology. J Immunol 185(7):4137-4147, 2010.
26. Sung BS, Chonmaitree T, Broemeling LD, Owen MJ, Patel JA, Hedgpeth DC, Howie VM: Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media. Clin Infect Dis 17(1):38-42, 1993.
27. Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo MB, Kebadze T, Aniscenko J, Oleszkiewicz G, Gray K, et al.: Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(11):1117-1124, 2012.
28. Kirchberger S, Majdic O, Steinberger P, Bluml S, Pfistershammer K, Zlabinger G, Deszcz L, Kuechler E, Knapp W, Stöckl J: Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol 175(2):1145-1152, 2005.
29. Oliver BG, Lim S, Wark P, Laza-Stanca V, King N, Black JL, Burgess JK, Roth M, Johnston SL: Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 63(6):519-525, 2008.
30. Gern JE, Joseph B, Galagan DM, Borcherding WR, Dick EC: Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism. J Infect Dis 174(6):1143-1150, 1996.
31. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, Wittkowski KM, Piqueras B, Banchereau J, Palucka AK, et al.: Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109(5):2066-2077, 2007.
32. Zaas AK, Chen M, Varkey J, Veldman T, Hero AO 3rd, Lucas J, Huang Y, Turner R, Gilbert A, Lambkin-Williams R, et al.: Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6(3):207-217, 2009.
33. Liu TY, Burke T, Park LP, Woods CW, Zaas AK, Ginsburg GS, Hero AO: An individualized predictor of health and disease using paired reference and target samples. BMC Bioinformatics 17(1):47, 2016.
34. Hotchkiss RS, Moldawer LL: Parallels between cancer and infectious disease. N Engl J Med 371(4):380-383, 2014.